Do we need to move beyond behavioural epidemiology? P revalence and incidence of sexually transmitted infections (STIs) vary across societies 1 and across sub populations defined by age, raceethnicity, and socioeconomic status. 2 3 The efforts to account for such variation and explain it, that can be found in the STD literature, have in general not differentiated between individual and population level health, or between population and individual level determi nants of individual STD outcomes. 4 Per haps this pattern reflects the predomi nant paradigm in modern epidemiology which has been termed the "risk factor" paradigm and has been linked to "bio medical individualism" as its underlying theoretical foundation. 5 6 This theoretical approach views populations simply as reflective of individual cases while con sidering social determinants of disease to be at best secondar y, if not irrelevant. 7 In the past several years, the risk factor paradigm in epidemiology has been seri ously challenged by leading epidemiolo gists 8 9 and a new paradigm that would emphasise the broader context of indi vidual risk factors has been called for. It has been suggested that whereas tra ditional epidemiologists ask the question "Why are some individuals healthy and others not?" the social epidemiologist is concerned with the question "Why are some societies healthy while others are not?" 10 Social epidemiology has focused on features of the economy, culture, poli tics, and the law. Examples of societal characteristics that have received atten tion include macroeconomic factors such as poverty, unemployment, and income distribution; and features of social rela tionships such as social cohesion, social exclusion, and sex and race relationships. 11 Also, a renewed interest in effects of neighbourhood environ ments on morbidity and mortality has emerged. [12] [13] [14] Work in social epidemiology has em phasised neighbourhoods and the com munity; and considerations of social capital and collective efficacy have usu ally been applied to chronic diseases, mortality, violence, and mental health as health outcomes. Infectious diseases and, particularly, their modes of trans mission are often ignored in this litera ture. Moreover, the social epidemiologi cal approach is often successful in the description of social correlates of mor bidity and mortality; identification of mechanisms of action through which social determinants influence levels and distribution of morbidity in populations tends to be more difficult.
Social epidemiological approaches may have a lot to offer to the explanation of STD differentials within and across societies. Conversely, STD epidemiology, with its distinct transmission dynamics may provide detailed examples of mechanisms of action through which social determinants operate. What fol lows is a description of one possible way in which relations among social determi nants, their mechanisms of action, and their impact on STD morbidity may be conceptualised.
THE SOCIAL NETWORKS APPROACH IN STD EPIDEMIOLOGY
During the past decade an important trend in STD epidemiology research has focused on the role of sexual networks in the spread of STIs in populations. Find ings demonstrated that in the United States, the higher rates of sexual contact between the "core" group and the "periphery" among African Americans facilitate the spread of infection overflow into the African American general popu lation; whereas the "sexual segregation" of African Americans from other racialethnic groups results in STIs remaining inside this population. 15 16 Other studies have shown that linkages between sexual networks are necessar y for the spread of STIs across sexual networks 17 ; that so called "core groups" appear to be important in the spread of STIs and in their prevention [18] [19] [20] ; and that the sexual transmission of sexually transmitted diseases (STDs) and HIV beyond core groups may depend on people who have sexual intercourse with members of core groups and with members of the general population-so called "bridge " 17 populations. Studies in Thailand and other populations revealed that large propor tions of men in certain occupa tions, such as truck drivers, the police, and the military tend to function as EDITORIALS "bridges" between female sex workers and their wives or girlfriends. 21 22 How ever, one study conducted in Seattle found the proportion of infection attrib utable to bridge populations to be re markably small; with most of the disease burden for gonococcal and chlamydial infections in both high prevalence and low prevalence subpopulations being attributable to mixing within the sub population or to direct mixing with members of high prevalence subpopulations. 23 It appears that bridge populations play a very important part in the introduction of infection into sub populations, once the infection is intro duced, most of the disease burden is attributable to mixing within the sub population.
Other studies conducted in Canada reveal that sexual network patterns involved in STD epidemics vary across phases of epidemics 24 and that during later phases of STD epidemics, the majority of sexual networks involved in the epidemic are not restricted to one geographic area 25 ; frequent contact be tween network members from a small group of northern reser ves and individu als in the major souther n population centre of Winnipeg have formed bridges of transmission between these commu nities. Similarly, a study of elimination and reintroduction of primary and sec ondary syphilis in Seattle showed that characteristics of persons with primary and secondar y syphilis varied across epi demic spread, elimination, and reintro duction periods. 26 There were significant differences between cases during the various epidemic phases with respect to age, sex, ethnicity, drug use, and involve ment with commercial and anonymous sex. Moreover, during all phases, im ported cases differed from locally ac quired cases with respect to age, sex, ethnicity, and drug use behaviours.
One network pattern that has received increasing research attention in recent years is concurrent partnerships, or sexual partnerships that overlap over time. 27 Concurrent partnerships acceler ate the spread of an STI through a popu lation by removing the protective factors of time and sequence inherent in serial monogamy.
Sexual networks and patterns of sexual partnership formation and disso lution constitute a major mechanism of action through which the political economy and the sociolegal system in fluence the rate of spread of STI in a population; availability, accessibility, and utilisation of appropriate health care, and availability and utilisation of con doms being others.
CREATION, MAINTENANCE, AND EVOLUTION OF CORE GROUPS
Sexual networks that are highly critical to the rate of spread of STI include sex www.sextransinf.com EDITORIALS work; exchange of sex for gifts, material needs or drugs; and anonymous sex. The creation, maintenance, and expansion of sex in exchange for money or other goods appears to be highly sensitive to changes in political economy and the sociolegal system. Internal conflicts, war, economic crises, and social collapse are accompanied by the establishment of major sex markets or the expansion of existing ones. For example, in Moscow, Russia, before the August 1998 economic crisis the number of female sex workers was estimated at 15 000-30 000; follow ing the crisis this number increased to 30 000-90 000. 28 Similarly, in Jakarta and Surabaya, Indonesia, between 1997 and 1998-during which time the mon etary crisis occurred-the percentage of female sex workers who were less than 20 years of age increased by 38% and 125% respectively; the percentage of female sex workers with less than 12 months' experience increased by 28% and 130% during the same period in these two cities. 29 A decade of conflict in the Balkan region and the poverty of post communist eastern Europe have created a major network of trafficking in women which reaches across eastern Europe, Balkans, the Middle East, and Western Europe. 30 Globalisation, charac terising many social, economic, and behavioural patterns, includes sex work and expands the volume of sex workers.
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The political economy and the socio legal system and any changes in them systematically impact lower socioeco nomic status, minority groups to a greater extent than others. Sociolegal systems tend to reinforce existing hier archies and protect the privileged. Thus, social parameters often create the con text which facilitates the creation, main tenance, and expansion of sexual net works that cause rapid spread of STD among minority racial, ethnic, and socioeconomic groups and in less devel oped societies. The same context associ ates longer duration of infection with the less privileged groups and less privi leged societies through differential ac cess to, and differential utilisation of, good quality STD care. A detailed de scription of the sociopolitical context in which African Americans live in the rural southeaster n United States power fully elucidates how contextual features including racism, discrimination, lim ited employment opportunity, and re sultant social and economic inequity may promote sexual network patterns that transmit STIs. 33 Despite the powerful effects of social context and social determinants embed ded in political economy and sociolegal systems on the level and distribution of STDs, most of our research and surveil lance attention focuses on the STDs themselves and to a limited extent on the individual behaviours associated with STD acquisition. It is important to develop standard techniques for summarising the extent and nature of sex work within populations and for determining the size and nature of the interactions among core groups, bridge populations, and the general population. Moreover, most research and surveillance activity tends to be conducted within local boundaries, without much attention to sexual links that relate many local sexual networks to each other. Given that prevalence of sex work seems dependent on global forces, and that sex workers seem to be highly mobile across geo graphic areas, it may be important to consider the establishment of surveil lance systems that include monitoring of contextual parameters and social deter minants at regional and global levels.
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STD prevention programmes may be more effective if informed about the local, regional, and global context in which STD rates rise and fall; and which create the inequalities in STD incidence across societies and across groups de fined by race-ethnicity and socioeco nomic status. T he cancer burden causally associated with human papillomavirus (HPV) infections is high. Cervical cancer is the second most common cancer among females in the world, with 500 000 new cases and 300 000 premature deaths a year. Because of the long preclinical period cervical cancer can be prevented by screening, diagnosis, and treatment of premalignant cervical lesions, but for developing countries preventive vaccina tion may be the only possibility to significantly reduce cervical cancer inci dence. Also in the developed countries considerable gains at the individual and societal level would be obtained, if a sig nificant proportion of cervical cancer and its precursor lesions could be pre vented by HPV vaccination (for a system atic review see Lehtinen et al 2 ). In addition, other anogenital cancers, oropharyngeal and base of tongue can cers, and probably a small propor tion of oesophageal cancers are all strongly associated with past HPV infection.
3-5 For these and other possible HPV associated cancers, vaccination may be the only possibility for prevention. Overall pre vention of HPV infections may result in a 5-10% reduction of cancer mortality worldwide. This editorial seeks to answer the following two questions: what kind of vaccines will be tested and how should their efficacy be defined?
Preventive HPV vaccines entering clinical efficacy (phase III) trials are plain virus-like particles (VLPs), DNA free capsids comprising the major viral capsid (L1) protein (manufactured by Merck, GlaxoSmithKline, and by NIH), or chimeric VLPs (CVLP), containing various combinations of early viral pro teins attached in different ways to the major L1 or the minor (L2) capsid proteins of the virus.
In phase I and II trials HPV VLPs have proved to be safe and highly immunogenic.
6 HPV VLP immunisation induces approximately 100-fold higher neutralising antibody titres than natural infection. The level of mucosal immu noglobulin G (IgG) is 10% but it varies following the menstrual cycle and is lowest at the time of ovulation. The pre vailing theory of the mode of action of the vaccine, however, suggests that this variation may not be a major problem. In natural infection the entry of HPV into the basal cells of the epithelium, which support the initial stages of viral replica tion, is facilitated by a microscopic trauma resulting from, for example, sexual intercourse. Following this micro trauma, circulating antibodies leak to the epithelial surface and neutralise the virus.
The L1 antibodies recognise a confor mational, type specific epitope, and have shown close to a 100% protection in ani mal studies against homologous chal lenges with both HPV and animal papillomaviruses. 7 While the increas ingly large number of oncogenic HPV types (16, 18, 31, 33, 35, 45, 51, 52, 58, 59 ) that associate with cervical cancer may make it impossible to achieve 100% pro tection against cervical cancer, it is relatively easy to include the most preva lent oncogenic HPVs (HPV16 and HPV18) into a multivalent VLP vaccine, and even tailor the vaccine composition by the HPV types most prevalent in different geographic areas should this prove necessar y.
Analogously to hepatitis B virus (HBV) vaccine HPV VLPs also induce cytotoxic T cell (CTL) responses by entering the MHC class I pathway. 7 If the antibodies fail to neutralise all HPV virions, CTLs recognising viral capsids bound for as long as 10-12 hours to more or less specific cellular receptors (in tegrin and/or heparan sulphate proteo glycans 8 9 ) might block spread of the virus at its most primordial state in the initially infected cells. Production of new virions takes place in the upper layers of the epithelium, and CTLs targeting these cells might effectively reduce spread of the virus. Indication of this has, however, been shown only for the non-oncogenic HPV VLPs, and it is not clear whether such a response is able to eliminate oncogenic HPVs from the basal cells. 10 CVLPs may offer a significant advan tage in this regard. The expression of various early HPV proteins responsible for viral replication (E1), transcription (E2), and oncogenesis (E6, E7) is abun dant both in the basal and the differenti ating epithelial cells providing good targets for the CTLs. Two vaccines based on different gene constructs-HPV16 L1, L2 truncated E2-E7 CVLP (by an NIH group) and HPV16 L1-E7 CVLP (by Medigene)-have passed or are passing safety and immunogenicity tests. In addition to the induction of high titres of neutralising antibodies, some of which (anti-L2 antibodies) may be cross protec tive against several HPV types, the CVLP vaccines induce CTL responses against the early proteins in humans. 11 However, for CVLPs data on humans are scarce and need to be expanded. CTL responses against the early HPV proteins are important not only in order to provide theoretically improved protection and possible therapeutic effect, but because they may also offer cross protection against several HPV types. The E1 and E2 proteins are particularly well conser ved among the HPVs.
The analogy between the different HPV VLP vaccines and the first human cancer vaccine, HBV vaccine, is very encouraging. The HBV vaccine has an overall efficacy of 95%, 12 and even when given to infants born to mothers with active hepatitis (HBV-e antigen positive women, the offspring of whom are prone to become chronic HBV carriers) its effi cacy exceeds 75%. These figures also fit the first available data on long term effects of universal HBV vaccination. The incidence of liver cancer has reduced by 75% among 12-14 year old Taiwanese children 15 years after implementation of the nationwide HBV vaccination programme. 13 This was to be expected on the basis of seroepidemiological data showing that HBs antibody positive
